COVID19 Vaccine Archives - Page 3 of 16

February 7, 2022

During period of delta predominance, protection was lower among vaccinated persons without previous COVID-19 diagnosis

February 3, 2022

After mRNA-1273 boost, neutralization titers against the omicron variant 20.0 times higher than than those at 1 month after second dose

By

Diana Ernst, RPh

February 1, 2022

Findings from an ongoing randomized, placebo-controlled, observer-blind phase 3 trial showed Spikevax was 93.2% effective at preventing COVID-19.

January 31, 2022

Vaccine, which has been available for the age group under emergency use authorization, will be marketed as Spikevax

News

January 28, 2022

However, odds ratios were higher for omicron suggesting that booster doses are less protective than against delta

January 28, 2022

Compared with homologous booster, heterologous booster with mRNA-based vaccine yielded larger increase in binding antibodies

January 27, 2022

Supreme Court said mandate went too far in imposing such a sweeping requirement on employers

January 26, 2022

New US study will assess the updated, omicron-targeted vaccine for use as a booster or for primary vaccinations

January 24, 2022

But protection against COVID-19 hospitalization, death after 2 doses of BNT162b2 or CHAdOx1-S is more durable

January 21, 2022

The NCCN Advisory Committee supports the strong preference for mRNA vaccines and offers guidance on the timing of vaccination